Barry Datlof is the Director, Medical Technology Transfer at the U.S. Army Medical Research and Materiel Command. He has commercialized biomedical and IT technologies in the university, non-profit, for-profit, and government sectors. This includes therapeutics, vaccines, diagnostics, medical devices, and medical IT. He owns Pregmama, a female fertility company developing therapies for women over 35. He teaches marketing at the NIH FAES graduate school and at the Johns Hopkins Masters program in Biotechnology. Currently, he serves on the board of directors for BioMetrx, a cancer theranostics company, and AlphaGenics, a wellness genetics company. Mr. Datlof was COO of Tolergenics, an immune tolerance company, and VP Business Development for a pathogen diagnostics company. He also invented the first XML-based worldwide search engine for licensable technologies, BirchBob. He previously was Director of Patents and Licensing at the American Red Cross, and he founded the Office of Technology Transfer at the Dana-Farber Cancer Institute in Boston. His education includes a bachelor's in Biology from Swarthmore College and a master's in business administration from the University of Chicago. He has lectured on many patent and licensing topics, including technology transfer espionage, biotech branding, knowledge management solutions for startups and tech transfer offices, software commercialization, government trademark licensing, technology transfer ethics, and FDA Tropical Disease Vouchers.